Chemomab Therapeutics (CMMB) Short Interest Ratio & Short Volume → Wall Street legend who predicted 2021 tech crash issues new warning (From Chaikin Analytics) (Ad) Free CMMB Stock Alerts $0.87 -0.01 (-1.13%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Chemomab Therapeutics Short Interest DataCurrent Short Volume116,700 sharesPrevious Short Volume155,800 sharesChange Vs. Previous Month-25.10%Dollar Volume Sold Short$81,690.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares11,050,000 sharesFloat Size11,870,000 sharesShort Percent of Float0.98%Today's Trading Volume55,066 sharesAverage Trading Volume190,321 sharesToday's Volume Vs. Average29% Short Selling Chemomab Therapeutics ? Sign up to receive the latest short interest report for Chemomab Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCMMB Short Interest Over TimeCMMB Days to Cover Over TimeCMMB Percentage of Float Shorted Over Time Ad Stocks NewsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarRevolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 Chemomab Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024116,700 shares $81,690.00 -25.1%1.0%0.5 $0.70 4/15/2024155,800 shares $113,734.00 -29.8%1.3%0.7 $0.73 3/31/2024221,900 shares $172,860.10 +14.3%1.9%1 $0.78 3/15/2024194,200 shares $155,224.06 -20.5%1.8%0.8 $0.80 2/29/2024244,300 shares $167,345.50 +549.7%2.5%0.9 $0.69 2/15/202437,600 shares $22,936.00 +15.7%0.4%0.1 $0.61 Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202432,500 shares $18,752.50 +5.5%0.3%0 $0.58 1/15/202430,800 shares $17,217.20 -23.8%0.3%0 $0.56 12/31/202340,400 shares $20,604.00 +125.7%0.3%0 $0.51 12/15/202317,900 shares $9,039.50 -84.8%0.1%0 $0.51 11/30/2023117,900 shares $63,548.10 +287.8%1.2%0.1 $0.54 11/15/202330,400 shares $24,836.80 -5.6%0.3%0 $0.82 10/31/202332,200 shares $23,583.28 -28.1%0.3%1.7 $0.73 10/15/202344,800 shares $39,827.20 -2.6%0.5%2.4 $0.89 9/30/202346,000 shares $41,170.00 +23.0%0.5%2 $0.90 9/15/202337,400 shares $40,766.00 -9.2%0.4%0.7 $1.09 8/31/202341,200 shares $45,732.00 -8.9%0.4%0.2 $1.11 8/15/202345,200 shares $50,624.00 -19.6%0.5%0.3 $1.12 7/31/202356,200 shares $71,936.00 -43.4%0.5%0.3 $1.28 7/15/202399,200 shares $139,872.00 +6.6%0.9%0.6 $1.41 6/30/202393,100 shares $121,961.00 -69.1%1.1%0.5 $1.31 6/15/2023301,700 shares $512,890.00 -7.6%3.4%1.8 $1.70 5/31/2023326,500 shares $512,605.00 -22.8%3.7%11.9 $1.57 5/15/2023422,900 shares $689,327.00 -7.3%4.8%5.7 $1.63 4/30/2023456,300 shares $679,887.00 -11.8%4.9%1 $1.49 4/15/2023517,400 shares $838,188.00 +1.5%5.6%1.1 $1.62 3/31/2023510,000 shares $810,900.00 -15.7%5.5%1.1 $1.59 3/15/2023605,200 shares $913,852.00 -8.2%7.1%0.7 $1.51 2/28/2023658,900 shares $1.02 million +457.9%7.7%0.8 $1.55 2/15/2023118,100 shares $237,381.00 +3.9%1.4%0.1 $2.01 1/31/2023113,700 shares $261,510.00 -24.8%1.4%0.3 $2.30 1/15/2023151,200 shares $341,712.00 +269.7%1.8%0.3 $2.26 12/30/202240,900 shares $130,880.00 -19.7%0.5%0.1 $3.20 12/15/202250,900 shares $109,435.00 +155.8%0.6%1 $2.15 11/30/202219,900 shares $41,790.00 -69.9%0.3%0.5 $2.10 11/15/202266,100 shares $134,844.00 +66,000.0%0.8%1.6 $2.04 10/31/2022100 shares $204.00 No ChangeN/A0 $2.04 10/15/2022100 shares $200.00 -93.3%N/A0 $2.00 9/30/20221,500 shares $3,735.00 -83.0%0.0%0 $2.49 9/15/20228,800 shares $28,776.00 -36.7%0.1%0.2 $3.27How to Play the AI and Crypto Markets in One Swing (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. CMMB Short Interest - Frequently Asked Questions What is Chemomab Therapeutics' current short interest? Short interest is the volume of Chemomab Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 116,700 shares of CMMB short. 0.98% of Chemomab Therapeutics' shares are currently sold short. Learn More on Chemomab Therapeutics' current short interest. What is a good short interest percentage for Chemomab Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.98% of Chemomab Therapeutics' floating shares are currently sold short. Is Chemomab Therapeutics' short interest increasing or decreasing? Chemomab Therapeutics saw a decrease in short interest in April. As of April 30th, there was short interest totaling 116,700 shares, a decrease of 25.1% from the previous total of 155,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Chemomab Therapeutics' float size? Chemomab Therapeutics currently has issued a total of 11,050,000 shares. Some of Chemomab Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Chemomab Therapeutics currently has a public float of 11,870,000 shares. How does Chemomab Therapeutics' short interest compare to its competitors? 0.98% of Chemomab Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Chemomab Therapeutics: Molecular Templates, Inc. (4.68%), Alterity Therapeutics Limited (1.03%), NuCana plc (1.21%), Galera Therapeutics, Inc. (7.34%), Addex Therapeutics Ltd (1.85%), Aeterna Zentaris Inc. (0.34%), Guardion Health Sciences, Inc. (14.33%), Moleculin Biotech, Inc. (1.45%), MIRA Pharmaceuticals, Inc. (0.42%), Avalo Therapeutics, Inc. (10.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Chemomab Therapeutics stock? Short selling CMMB is an investing strategy that aims to generate trading profit from Chemomab Therapeutics as its price is falling. CMMB shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Chemomab Therapeutics? A short squeeze for Chemomab Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CMMB, which in turn drives the price of the stock up even further. How often is Chemomab Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMMB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Molecular Templates Short Interest Data Alterity Therapeutics Short Interest Data NuCana Short Interest Data Galera Therapeutics Short Interest Data Addex Therapeutics Short Interest Data Aeterna Zentaris Short Interest Data Guardion Health Sciences Short Interest Data Moleculin Biotech Short Interest Data MIRA Pharmaceuticals Short Interest Data Avalo Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMMB) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders